Nantong Hospital of Traditional Chinese Medicine, Nantong, People's Republic of China.
Fujian University of Traditional Chinese Medicine, Fuzhou, People's Republic of China.
J Spinal Cord Med. 2023 Jul;46(4):632-648. doi: 10.1080/10790268.2022.2129154. Epub 2023 Jan 9.
Despite a high urinary tract infection (UTI) rate in spinal cord injured patents in China, there is limited evidence on the epidemiological character of that.
The purpose of our article was to characterize the distribution of pathogens of UTI patients with spinal cord injuries (SCI) and the resistance profile of pathogens.
A literature search of six electronic databases was carried out to identify the incidence, pathogen distribution, and drug resistance of UTI after SCI based on our inclusion and exclusion criteria. Meta-analysis was carried out using R 4.0.2 software; a subgroup analysis was performed by the year 2012.
We screened 1110 eligible studies, 33 were included in our final review. A total of 7271 bacterial species were included in our studies; 6092 were gram-negative (81.13% [76.83-85.11]) and 1003 were gram-positive (14.89% [11.70-18.38]). Before 2012, (45.43%) was the predominant isolated pathogen, followed by Klebsiella (7.49%) and Enterococcus (6.01%). After 2012, (50.23%) was the main pathogen, followed by Klebsiella (12.47%) and Proteus (6.88%). was more likely to be resistant to Levofloxacin, Amikacin, sulfonamides, 4th-generation cephalosporins and Nitrofurantoin before 2012 (81.8% vs. 62.9%, 32.0% vs. 7.6%, 81.3% vs. 61.6%, 81.8% vs. 24.1%, 33.5% vs. 5.1%), whereas was more frequently resistant to Inhibitor-resistant β-lactamas after 2012 (56.3% vs. 34.0%). was more likely to be resistant to Aztreonam, Amikacin before 2012 (80.0% vs. 39.8%, 48.1% vs. 19.0%). presented a high resistance to Levofloxacin, Inhibitor-resistant β-lactamas after 2012 (61.8% vs. 35.6%, 59.1% vs. 5.7%).
UTI in patients with SCI in China were mainly caused by gram-negative bacteria. We observed a remarkable modification in resistance profiles of pathogen distribution before 2012 and after 2012, which suggests reasonable control of the use of antibiotics has a positive effectiveness on resistance profiles.
尽管中国脊髓损伤患者的尿路感染(UTI)发生率很高,但关于其流行病学特征的证据有限。
本文旨在描述脊髓损伤(SCI)患者 UTI 的病原体分布特征和病原体耐药谱。
根据纳入和排除标准,我们对 6 个电子数据库进行了文献检索,以确定 SCI 后 UTI 的发病率、病原体分布和耐药情况。使用 R 4.0.2 软件进行荟萃分析;通过 2012 年进行亚组分析。
我们筛选了 1110 篇符合条件的研究,其中 33 篇纳入最终综述。我们的研究共纳入 7271 种细菌;6092 种为革兰氏阴性菌(81.13%[76.83-85.11]),1003 种为革兰氏阳性菌(14.89%[11.70-18.38])。2012 年之前, (45.43%)是主要的分离病原体,其次是克雷伯菌(7.49%)和肠球菌(6.01%)。2012 年之后, (50.23%)是主要病原体,其次是克雷伯菌(12.47%)和变形杆菌(6.88%)。2012 年之前, (81.8%比 62.9%,32.0%比 7.6%,81.3%比 61.6%,81.8%比 24.1%,33.5%比 5.1%)更可能对左氧氟沙星、阿米卡星、磺胺类药物、四代头孢菌素和呋喃妥因耐药,而 2012 年之后, (56.3%比 34.0%)更易对抑制β-内酰胺耐药。2012 年之前, (80.0%比 39.8%,48.1%比 19.0%)更可能对氨曲南和阿米卡星耐药。2012 年之后, (61.8%比 35.6%,59.1%比 5.7%)对左氧氟沙星和抑制β-内酰胺耐药有较高的耐药性。
中国脊髓损伤患者的 UTI 主要由革兰氏阴性菌引起。我们观察到 2012 年之前和之后,病原体分布的耐药谱发生了显著变化,这表明合理控制抗生素的使用对耐药谱具有积极的效果。